New findings could boost
type 1 diabetes treatment
Send a link to a friend
[February 29, 2016]
By Jim Dury
For six weeks seven-year-old Bethan
Westcott-Storer was feeling listless and losing weight, worrying parents
Lizzie and Dean. Now aged nine, she's the picture of health, having been
diagnosed with type 1 diabetes in November 2014, since when she's been
treating herself via an omnipod pump that delivers insulin via a cannula
under her skin.
"I felt very weak and tired all the time, and if my friends in the
playground said 'do you want to play It?' or something, I'd just
feel like 'ohh, not really," Bethan told Reuters during a check-up
at the University of Exeter Medical School.
According to her mother, "we noticed that she'd become quite thin,
she'd lost a lot of weight, but she didn't have all of the signs
that other children normally have with type 1 - she didn't have the
excess thirst and urinating. Just lost a lot of weight, so she's
been diagnosed for 15 months now."
Exeter scientists have revealed that children diagnosed before the
age of seven develop a more aggressive form of the disease than that
seen in teenagers. Their research could open up new, differing,
treatments for both teenagers and young children. It could even help
scientists develop a vaccine that prevents children developing
Working alongside scientists from the University of Oslo, the team,
led by Professor Noel Morgan and Dr Sarah Richardson, analyzed 100
pancreas samples from people diagnosed with type 1 diabetes shortly
before their death. The samples are housed at the Exeter Archival
Diabetes Biobank, the world's largest pancreas collection.
According to Richardson, a JDRF career development fellow, "those
samples are extremely important because we do not understand the
underlying disease process that goes on in these individuals and
it's that recent diagnosis that's critical for us to actually look
inside the pancreas and see what is going wrong, and the pancreas
itself is an extremely inaccessible organ."
The study shows that children diagnosed with type 1 diabetes before
the age of seven suffer from insulitis, an inflammatory process
which kills off almost all the insulin-producing beta cells in their
pancreas. By contrast, those diagnosed as teenagers or older retain
unexpectedly large numbers of beta cells, albeit malfunctioning.
"The significance of these findings is that we find that the
individuals who are diagnosed young have a very different disease
profile to those that are diagnosed older, and that has important
implications for potential treatments in that those individuals that
are diagnosed young might benefit more from immunotherapeutic
therapies, whereas those that are diagnosed older we might need to
look at different therapies that reactivate their sleeping beta
cells at the same time as applying immunotherapeutic drugs to
prevent any reactivation of an immune response," said Richardson.
[to top of second column]
Morgan told Reuters "it's always been thought that when people get
type 1 diabetes they've lost as many as 90 percent of their insulin
producing cells from their pancreas. What we've found is that while
that might be the case for the younger children it certainly doesn't
appear to be true for those that are older. They have quite a
considerable reserve of cells left. That's a new insight and it
might mean that if we could reactivate those cells we could help
them to cope better with their illness."
The team's discovery also has implications for the younger group.
"We might even be able to stop people getting the illness who
otherwise might," said Morgan. "That's our real hope, that we might
have a way of stopping children from becoming diabetic by
understanding the process and targeting it more specifically."
He added: "We're trying to understand what the trigger is and it may
be possible to use a vaccine to stop the triggering process, but it
might also be able to use a different kind of vaccine to target the
specific immune cells that are causing the illness, and that's where
the excitement lies."
According to type 1 diabetes charity JDRF (formerly known as the
Juvenile Diabetes Research Foundation), which part funded the
research, a child diagnosed with type 1 diabetes at the age of five
faces up to 19,000 insulin injections and 50,000 finger-prick blood
tests before they are 18.
Bethan Westcott-Storer hopes the Exeter team will succeed. "One day
in the future they find a cure lots and lots of people are going to
be really happy," she said.
The research, which received European Union backing, was published
online in the journal Diabetes.
[© 2016 Thomson Reuters. All rights
Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.